Back to BMRN
VANGUARD GROUP INC BMRN Position History
BioMarin Pharmaceutical Inc. • Healthcare
Quarters held
24
Latest value
$69.4M
Q4 2025
Peak value
$1.3B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $5.8M |
| Q1 2025 | $71K |
| Q1 2025 | $1.3B |
| Q1 2025 | $19.7M |
| Q1 2025 | $6.2M |
| Q1 2025 | $1.8M |
| Q2 2025 | $5M |
| Q2 2025 | $55K |
| Q2 2025 | $1B |
| Q2 2025 | $16M |
| Q2 2025 | $5M |
| Q2 2025 | $1.3M |
| Q3 2025 | $4.8M |
| Q3 2025 | $59.9M |
| Q3 2025 | $932.1M |
| Q3 2025 | $5.2M |
| Q3 2025 | $4.4M |
| Q3 2025 | $54K |
| Q4 2025 | $3.3M |
| Q4 2025 | $60K |
| Q4 2025 | $990.4M |
| Q4 2025 | $9.3M |
| Q4 2025 | $4.8M |
| Q4 2025 | $69.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $69.4M | 1.17M | — | — |
| Q4 2025 | $4.8M | 80.5K | — | — |
| Q4 2025 | $9.3M | 156.1K | — | — |
| Q4 2025 | $990.4M | 16.67M | — | — |
| Q4 2025 | $60K | 1.0K | — | — |
| Q4 2025 | $3.3M | 56.3K | — | — |
| Q3 2025 | $54K | 1.0K | — | — |
| Q3 2025 | $4.4M | 80.6K | — | — |
| Q3 2025 | $5.2M | 95.5K | — | — |
| Q3 2025 | $932.1M | 17.21M | — | — |
| Q3 2025 | $59.9M | 1.11M | — | — |
| Q3 2025 | $4.8M | 89.0K | — | — |
| Q2 2025 | $1.3M | 24.0K | — | — |
| Q2 2025 | $5M | 90.2K | — | — |
| Q2 2025 | $16M | 290.3K | — | — |
| Q2 2025 | $1B | 18.51M | — | — |
| Q2 2025 | $55K | 1.0K | — | — |
| Q2 2025 | $5M | 91.1K | — | — |
| Q1 2025 | $1.8M | 25.3K | — | — |
| Q1 2025 | $6.2M | 88.0K | — | — |
| Q1 2025 | $19.7M | 278.8K | — | — |
| Q1 2025 | $1.3B | 18.53M | — | — |
| Q1 2025 | $71K | 1.0K | — | — |
| Q1 2025 | $5.8M | 82.4K | — | — |
Other funds holding BMRN
$1.4B
$1.3B
$1.3B
$1.3B
$1.2B
$1.2B
$1.1B
$1.1B